983 related articles for article (PubMed ID: 27239107)
1. Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association.
Principi M; Cassano N; Contaldo A; Iannone A; Losurdo G; Barone M; Mastrolonardo M; Vena GA; Ierardi E; Di Leo A
World J Gastroenterol; 2016 May; 22(20):4802-11. PubMed ID: 27239107
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors for Hidradenitis Suppurativa in Patients with Inflammatory Bowel Disease.
Lukach AJ; Saul MI; Ferris LK; Swoger JM
Dig Dis Sci; 2018 Mar; 63(3):755-760. PubMed ID: 29357084
[TBL] [Abstract][Full Text] [Related]
3. Causal association between inflammatory bowel disease and hidradenitis suppurativa: A two-sample bidirectional Mendelian randomization study.
Bao B; Zhu C; Shi J; Lu C
Front Immunol; 2023; 14():1071616. PubMed ID: 36776852
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study.
Deckers IE; Benhadou F; Koldijk MJ; Del Marmol V; Horváth B; Boer J; van der Zee HH; Prens EP
J Am Acad Dermatol; 2017 Jan; 76(1):49-53. PubMed ID: 27793450
[TBL] [Abstract][Full Text] [Related]
5. Ocular Manifestations in Inflammatory Bowel Disease Are Associated with Other Extra-intestinal Manifestations, Gender, and Genes Implicated in Other Immune-related Traits.
Taleban S; Li D; Targan SR; Ippoliti A; Brant SR; Cho JH; Duerr RH; Rioux JD; Silverberg MS; Vasiliauskas EA; Rotter JI; Haritunians T; Shih DQ; Dubinsky M; Melmed GY; McGovern DP
J Crohns Colitis; 2016 Jan; 10(1):43-9. PubMed ID: 26449790
[TBL] [Abstract][Full Text] [Related]
6. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa.
Eppinga H; Sperna Weiland CJ; Thio HB; van der Woude CJ; Nijsten TE; Peppelenbosch MP; Konstantinov SR
J Crohns Colitis; 2016 Sep; 10(9):1067-75. PubMed ID: 26971052
[TBL] [Abstract][Full Text] [Related]
7. Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota.
Yadav S; Singh S; Edakkanambeth Varayil J; Harmsen WS; Zinsmeister AR; Tremaine WJ; Davis MD; Wetter DA; Colombel JF; Loftus EV
Clin Gastroenterol Hepatol; 2016 Jan; 14(1):65-70. PubMed ID: 25952308
[TBL] [Abstract][Full Text] [Related]
8. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
9. Hidradenitis suppurativa and inflammatory bowel disease in a nested case-control study.
Neri B; Mossa M; Salvatori S; Appolloni V; Pensa C; Lambiase S; Lolli E; Calabrese E; Monteleone G; Bianchi L; Campione E; Biancone L
Dig Liver Dis; 2023 Apr; 55(4):490-495. PubMed ID: 36371384
[TBL] [Abstract][Full Text] [Related]
10. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
11. [Cutaneous involvement in chronic inflammatory bowel disease : Crohn's disease and ulcerative colitis].
Richter L; Rappersberger K
Hautarzt; 2016 Dec; 67(12):940-947. PubMed ID: 27830291
[TBL] [Abstract][Full Text] [Related]
12. Identification of Clinical and Genetic Parameters Associated with Hidradenitis Suppurativa in Inflammatory Bowel Disease.
Janse IC; Koldijk MJ; Spekhorst LM; Vila AV; Weersma RK; Dijkstra G; Horváth B
Inflamm Bowel Dis; 2016 Jan; 22(1):106-13. PubMed ID: 26422515
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of inflammatory bowel disease (IBD) in hidradenitis suppurativa (HS): systematic review and adjusted meta-analysis.
Phan K; Tatian A; Woods J; Cains G; Frew JW
Int J Dermatol; 2020 Feb; 59(2):221-228. PubMed ID: 31631340
[TBL] [Abstract][Full Text] [Related]
14. Management consensus of inflammatory bowel disease for the Asia-Pacific region.
Ouyang Q; Tandon R; Goh KL; Pan GZ; Fock KM; Fiocchi C; Lam SK; Xiao SD
J Gastroenterol Hepatol; 2006 Dec; 21(12):1772-82. PubMed ID: 17074013
[TBL] [Abstract][Full Text] [Related]
15. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.
Scheinfeld N
Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308
[TBL] [Abstract][Full Text] [Related]
16. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
17. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
18. Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study.
van der Zee HH; van der Woude CJ; Florencia EF; Prens EP
Br J Dermatol; 2010 Jan; 162(1):195-7. PubMed ID: 19681876
[TBL] [Abstract][Full Text] [Related]
19. The in-hospital burden of hidradenitis suppurativa in patients with inflammatory bowel disease: a decade nationwide analysis from 2004 to 2014.
Ramos-Rodriguez AJ; Timerman D; Khan A; Bonomo L; Hunjan MK; Lemor A
Int J Dermatol; 2018 May; 57(5):547-552. PubMed ID: 29431201
[TBL] [Abstract][Full Text] [Related]
20. Interaction of obesity and inflammatory bowel disease.
Harper JW; Zisman TL
World J Gastroenterol; 2016 Sep; 22(35):7868-81. PubMed ID: 27672284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
